COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Art Pappas to participate at Foundation Sante Biotechnology Conference at Samos, Greece
News | 07. 11. 2008
